Anti-CLIP1 / CLIP170 Antibody

貨號 Cat. No.
LS-B3615
規格 Size
50 µg 0.5 mg/ml
品牌 Brand
LSBio

Description

Anti-CLIP1 / CLIP170 Antibody LS-B3615

CLIP1 / CLIP170 Goat anti-Human Polyclonal Antibody

An IHC-plusTM AntibodyImmunohistochemistry: LS-B3615 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B3615 was determined to be 2.5 ug/ml. Learn more

CLIP1 / CLIP170 Antibody Details

Target: Human CLIP1 / CLIP170

Host: Goat

Reactivity: Dog, Human, Mouse, Pig, Porcine, Rat

Clonality: Polyclonal 

Purification: Immunoaffinity Chromatography

 Applications:

Immunohistochemistry - Paraffin (IHC-P) (2.5)

Western blot (WB) (1 - 3)

ELISA (1:8000) & (1 - 3)

Optimal dilution to be determined by the researcher.

 


CLIP1 / CLIP170 Antibody Specificity

Immunogen: CLIP1 / CLIP170 antibody was raised against synthetic peptide C-PHSTHHGSRGEERP from the C-terminus of human CLIP1 / CLIP170 (NP_002947.1; NP_937883.1). Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Gibbon (100%), Monkey (100%), Marmoset (93%), Mouse (93%), Rat (93%), Hamster (93%), Elephant (93%), Panda (93%), Bovine (93%), Dog (93%), Bat (93%), Horse (93%), Rabbit (93%), Pig (93%), Opossum (93%), Turkey (86%), Chicken (86%), Pufferfish (86%).

Specificity: Human CLIP1 / CLIP170. This antibody is expected to recognize both reported isoforms (NP_002947.1; NP_937883.1).


CLIP1 / CLIP170 Antibody Packaging

Presentation: Tris-buffered saline, pH 7.3, 0.5% BSA, 0.02% sodium azide

Storage: Store at -20°C. Minimize freezing and thawing.

Restrictions: For research use only.

 

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢